<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Recent work from our laboratory demonstrated that <z:chebi fb="0" ids="2981">baicalin</z:chebi> attenuates inflammatory reaction and <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> injury in rats </plain></SENT>
<SENT sid="1" pm="."><plain>Toll-like receptor 2 and 4 (TLR2/4) and the downstream nuclear factor-kappa B (NF-κB) signaling pathway, which mediate the inflammatory reaction, are involved in the pathophysiological processes of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In this study, we investigated whether <z:chebi fb="0" ids="2981">baicalin</z:chebi> inhibits TLR2/4 signaling pathway in a rat model of permanent focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Adult Sprague-Dawley rats underwent permanent middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="2981">Baicalin</z:chebi> was administered by intraperitoneally injected twice at 2 and 12 h after the <z:hpo ids='HP_0003674'>onset</z:hpo> of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> area and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume were measured 24 h after MCAO </plain></SENT>
<SENT sid="6" pm="."><plain>Expression of TLR2/4, NF-κB, inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase (iNOS), and cyclooxygenase-2 (COX-2) were determined by RT-PCR or western blot </plain></SENT>
<SENT sid="7" pm="."><plain>NO and <z:chebi fb="0" ids="15551">PGE2</z:chebi> production in rat brain were measured 24 h after MCAO </plain></SENT>
<SENT sid="8" pm="."><plain>Serum content of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha (TNF-α) and interleukin-1β (IL-1β) were detected by ELISA </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="2981">Baicalin</z:chebi> reduced cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> area and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="0" ids="2981">Baicalin</z:chebi> reduced the expression of TLR2/4 and NF-κB, decreased the expression and activity of iNOS and COX-2 in rat brain </plain></SENT>
<SENT sid="11" pm="."><plain><z:chebi fb="0" ids="2981">Baicalin</z:chebi> also attenuated the serum content of TNF-α and IL-1β </plain></SENT>
<SENT sid="12" pm="."><plain>Our results suggest that <z:chebi fb="0" ids="2981">baicalin</z:chebi> inhibits the TLR2/4 signaling pathway in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, which may be a mechanism underlying the <z:chebi fb="0" ids="2981">baicalin</z:chebi>'s neuroprotection </plain></SENT>
</text></document>